Multiple Drugmakers Developing Vaccines Against Pneumonia
November 01, 2022
The Wall Street Journal (10/31, Hopkins, Subscription Publication) reports drugmakers are working to upend Pfizer’s dominance in the global market for pneumonia vaccines, as companies including Merck, GSK, and Vaxcyte are developing shots to protect again...